<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>allergy and immunology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>allergy and immunology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Human ASXL1 Deficiency Causes Epigenetic Dysfunction, Combined Immunodeficiency and EBV-Associated Hodgkin Lymphoma
Authors: Fu, M. P.; Sharma, M.; Merrill, S. M.; Yousefi, P.; Tan, R.; Modi, B. P.; Del Bel, K.; Deyell, R. J.; Rozmus, J.; Rehmus, W.; Hildebrand, K. J.; James, E.; Blanchard-Rohner, G.; Lin, S.; Shopsowitz, K. E.; Setiadi, A.; Terry, J.; Lee, A. F.; Drogemoller, B. I.; Matthews, A.; Tarailo-Graovac, M.; Sauve, L.; Mitchell, H.; Prendiville, J.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/allergy-and-immunology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="allergy and immunology" />
<meta property="og:description" content="Human ASXL1 Deficiency Causes Epigenetic Dysfunction, Combined Immunodeficiency and EBV-Associated Hodgkin Lymphoma
Authors: Fu, M. P.; Sharma, M.; Merrill, S. M.; Yousefi, P.; Tan, R.; Modi, B. P.; Del Bel, K.; Deyell, R. J.; Rozmus, J.; Rehmus, W.; Hildebrand, K. J.; James, E.; Blanchard-Rohner, G.; Lin, S.; Shopsowitz, K. E.; Setiadi, A.; Terry, J.; Lee, A. F.; Drogemoller, B. I.; Matthews, A.; Tarailo-Graovac, M.; Sauve, L.; Mitchell, H.; Prendiville, J." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/allergy-and-immunology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2024-01-03T10:39:43+00:00" />
<meta property="article:modified_time" content="2024-01-03T10:39:43+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="allergy and immunology"/>
<meta name="twitter:description" content="Human ASXL1 Deficiency Causes Epigenetic Dysfunction, Combined Immunodeficiency and EBV-Associated Hodgkin Lymphoma
Authors: Fu, M. P.; Sharma, M.; Merrill, S. M.; Yousefi, P.; Tan, R.; Modi, B. P.; Del Bel, K.; Deyell, R. J.; Rozmus, J.; Rehmus, W.; Hildebrand, K. J.; James, E.; Blanchard-Rohner, G.; Lin, S.; Shopsowitz, K. E.; Setiadi, A.; Terry, J.; Lee, A. F.; Drogemoller, B. I.; Matthews, A.; Tarailo-Graovac, M.; Sauve, L.; Mitchell, H.; Prendiville, J."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "allergy and immunology",
      "item": "https://trxiv.yorks0n.com/posts/allergy-and-immunology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "allergy and immunology",
  "name": "allergy and immunology",
  "description": "Human ASXL1 Deficiency Causes Epigenetic Dysfunction, Combined Immunodeficiency and EBV-Associated Hodgkin Lymphoma\nAuthors: Fu, M. P.; Sharma, M.; Merrill, S. M.; Yousefi, P.; Tan, R.; Modi, B. P.; Del Bel, K.; Deyell, R. J.; Rozmus, J.; Rehmus, W.; Hildebrand, K. J.; James, E.; Blanchard-Rohner, G.; Lin, S.; Shopsowitz, K. E.; Setiadi, A.; Terry, J.; Lee, A. F.; Drogemoller, B. I.; Matthews, A.; Tarailo-Graovac, M.; Sauve, L.; Mitchell, H.; Prendiville, J.",
  "keywords": [
    
  ],
  "articleBody": " Human ASXL1 Deficiency Causes Epigenetic Dysfunction, Combined Immunodeficiency and EBV-Associated Hodgkin Lymphoma\nAuthors: Fu, M. P.; Sharma, M.; Merrill, S. M.; Yousefi, P.; Tan, R.; Modi, B. P.; Del Bel, K.; Deyell, R. J.; Rozmus, J.; Rehmus, W.; Hildebrand, K. J.; James, E.; Blanchard-Rohner, G.; Lin, S.; Shopsowitz, K. E.; Setiadi, A.; Terry, J.; Lee, A. F.; Drogemoller, B. I.; Matthews, A.; Tarailo-Graovac, M.; Sauve, L.; Mitchell, H.; Prendiville, J. S.; MacIsaac, J. L.; Dever, K.; Lin, D. T.; Meijer, M.; Ross, C. J.; Dobson, S. R.; Vercauteren, S. M.; Wasserman, W. W.; van Karnebeek, C. D.; McKinnon, M. L.; Kobor, M. S.; Turvey, S. E.; Biggs, C. M.\nScore: 6.4, Published: 2023-12-21 DOI: 10.1101/2023.12.20.23300096\nInborn errors of immunity (IEI) are a group of disorders caused by deleterious variants in immune-related genes, including some that function as epigenetic regulators. Additional sex combs-like 1 (ASXL1) is an epigenetic modifier that has not previously been linked to an IEI. Somatic ASXL1 variants are found in clonal hematopoiesis and hematologic neoplasms, while heterozygous germline variants cause Bohring-Opitz syndrome. We present a new IEI caused by biallelic germline variants in ASXL1. The patient had a complex and unusual history of disease progression notable for persistent cutaneous vaccine-strain rubella granulomas initially manifesting in early childhood, chronic macrocytosis and mild bone marrow cellular hypoplasia, and Epstein Barr virus- associated Hodgkin lymphoma in adolescence. Detailed immunophenotyping revealed progressive loss of B-cells, hypogammaglobinemia, and T-cell lymphopenia with severe skewing toward a memory phenotype and elevated expression of T-cell exhaustion and senescence markers. Molecular investigations confirmed ASXL1 protein deficiency in the patients T-cells and fibroblasts. The T-cells exhibited marked loss of DNA methylation, increased epigenetic aging, and CD8 T-cell dysfunction. These aberrations were ameliorated by lentivirus-mediated transduction with wild-type ASXL1, confirming the pathogenicity of ASXL1 variants. This study defines a novel human IEI caused by ASXL1 deficiency, a diagnosis that should be considered in individuals with chronic viral infections, virus-associated hematologic malignancies, and combined immunodeficiency. Furthermore, our findings provide fresh insights into the mechanisms underlying the roles of human ASXL1 in T-cell function as well as in the development and maintenance of lymphomas.\nUnveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapy\nAuthors: Bodansky, A.; Yu, D. J.; Rallistan, A.; Kalaycioglu, M.; Boonyaratanakornkit, J.; Green, D. J.; Gauthier, J.; Turtle, C. J.; Zorn, K.; O'Donovan, B.; Mandel-Brehm, C.; Asaki, J.; Kortbawi, H.; Kung, A. F.; Rackaityte, E.; Wang, C.-Y.; Saxena, A.; de Dios, K.; Masi, G.; Nowak, R. J.; O'Connor, K. C.; Li, H.; Diaz, V. E.; Casaletto, K. B.; Gontrum, E. Q.; Chan, B.; Kramer, J. H.; Wilson, M. R.; Utz, P. J.; Hill, J. A.; Jackson, S. W.; Anderson, M. S.; DeRisi, J. L.\nScore: 4.1, Published: 2023-12-20 DOI: 10.1101/2023.12.19.23300188\nThe prevalence and burden of autoimmune and autoantibody mediated disease is increasing worldwide, yet most disease etiologies remain unclear. Despite numerous new targeted immunomodulatory therapies, comprehensive approaches to apply and evaluate the effects of these treatments longitudinally are lacking. Here, we leverage advances in programmable-phage immunoprecipitation (PhIP-Seq) methodology to explore the modulation, or lack thereof, of proteome-wide autoantibody profiles in both health and disease. We demonstrate that each individual, regardless of disease state, possesses a distinct set of autoreactivities constituting a unique immunological fingerprint, or \"autoreactome\", that is remarkably stable over years. In addition to uncovering important new biology, the autoreactome can be used to better evaluate the relative effectiveness of various therapies in altering autoantibody repertoires. We find that therapies targeting B-Cell Maturation Antigen (BCMA) profoundly alter an individuals autoreactome, while anti-CD19 and CD-20 therapies have minimal effects, strongly suggesting a rationale for BCMA or other plasma cell targeted therapies in autoantibody mediated diseases.\n",
  "wordCount" : "613",
  "inLanguage": "en",
  "datePublished": "2024-01-03T10:39:43Z",
  "dateModified": "2024-01-03T10:39:43Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/allergy-and-immunology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      allergy and immunology
    </h1>
    <div class="post-meta">&lt;span&gt;updated on January 3, 2024&lt;/span&gt;

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.12.20.23300096">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.12.20.23300096" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.12.20.23300096">
        <p class="paperTitle">Human ASXL1 Deficiency Causes Epigenetic Dysfunction, Combined Immunodeficiency and EBV-Associated Hodgkin Lymphoma</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.12.20.23300096" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.12.20.23300096" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Fu, M. P.; Sharma, M.; Merrill, S. M.; Yousefi, P.; Tan, R.; Modi, B. P.; Del Bel, K.; Deyell, R. J.; Rozmus, J.; Rehmus, W.; Hildebrand, K. J.; James, E.; Blanchard-Rohner, G.; Lin, S.; Shopsowitz, K. E.; Setiadi, A.; Terry, J.; Lee, A. F.; Drogemoller, B. I.; Matthews, A.; Tarailo-Graovac, M.; Sauve, L.; Mitchell, H.; Prendiville, J. S.; MacIsaac, J. L.; Dever, K.; Lin, D. T.; Meijer, M.; Ross, C. J.; Dobson, S. R.; Vercauteren, S. M.; Wasserman, W. W.; van Karnebeek, C. D.; McKinnon, M. L.; Kobor, M. S.; Turvey, S. E.; Biggs, C. M.</p>
        <p class="info">Score: 6.4, Published: 2023-12-21 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.12.20.23300096' target='https://doi.org/10.1101/2023.12.20.23300096'> 10.1101/2023.12.20.23300096</a></p>
        <p class="abstract">Inborn errors of immunity (IEI) are a group of disorders caused by deleterious variants in immune-related genes, including some that function as epigenetic regulators. Additional sex combs-like 1 (ASXL1) is an epigenetic modifier that has not previously been linked to an IEI. Somatic ASXL1 variants are found in clonal hematopoiesis and hematologic neoplasms, while heterozygous germline variants cause Bohring-Opitz syndrome. We present a new IEI caused by biallelic germline variants in ASXL1. The patient had a complex and unusual history of disease progression notable for persistent cutaneous vaccine-strain rubella granulomas initially manifesting in early childhood, chronic macrocytosis and mild bone marrow cellular hypoplasia, and Epstein Barr virus- associated Hodgkin lymphoma in adolescence. Detailed immunophenotyping revealed progressive loss of B-cells, hypogammaglobinemia, and T-cell lymphopenia with severe skewing toward a memory phenotype and elevated expression of T-cell exhaustion and senescence markers. Molecular investigations confirmed ASXL1 protein deficiency in the patients T-cells and fibroblasts. The T-cells exhibited marked loss of DNA methylation, increased epigenetic aging, and CD8 T-cell dysfunction. These aberrations were ameliorated by lentivirus-mediated transduction with wild-type ASXL1, confirming the pathogenicity of ASXL1 variants. This study defines a novel human IEI caused by ASXL1 deficiency, a diagnosis that should be considered in individuals with chronic viral infections, virus-associated hematologic malignancies, and combined immunodeficiency. Furthermore, our findings provide fresh insights into the mechanisms underlying the roles of human ASXL1 in T-cell function as well as in the development and maintenance of lymphomas.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.12.19.23300188">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.12.19.23300188" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.12.19.23300188">
        <p class="paperTitle">Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapy</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.12.19.23300188" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.12.19.23300188" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Bodansky, A.; Yu, D. J.; Rallistan, A.; Kalaycioglu, M.; Boonyaratanakornkit, J.; Green, D. J.; Gauthier, J.; Turtle, C. J.; Zorn, K.; O&#39;Donovan, B.; Mandel-Brehm, C.; Asaki, J.; Kortbawi, H.; Kung, A. F.; Rackaityte, E.; Wang, C.-Y.; Saxena, A.; de Dios, K.; Masi, G.; Nowak, R. J.; O&#39;Connor, K. C.; Li, H.; Diaz, V. E.; Casaletto, K. B.; Gontrum, E. Q.; Chan, B.; Kramer, J. H.; Wilson, M. R.; Utz, P. J.; Hill, J. A.; Jackson, S. W.; Anderson, M. S.; DeRisi, J. L.</p>
        <p class="info">Score: 4.1, Published: 2023-12-20 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.12.19.23300188' target='https://doi.org/10.1101/2023.12.19.23300188'> 10.1101/2023.12.19.23300188</a></p>
        <p class="abstract">The prevalence and burden of autoimmune and autoantibody mediated disease is increasing worldwide, yet most disease etiologies remain unclear. Despite numerous new targeted immunomodulatory therapies, comprehensive approaches to apply and evaluate the effects of these treatments longitudinally are lacking. Here, we leverage advances in programmable-phage immunoprecipitation (PhIP-Seq) methodology to explore the modulation, or lack thereof, of proteome-wide autoantibody profiles in both health and disease. We demonstrate that each individual, regardless of disease state, possesses a distinct set of autoreactivities constituting a unique immunological fingerprint, or &#34;autoreactome&#34;, that is remarkably stable over years. In addition to uncovering important new biology, the autoreactome can be used to better evaluate the relative effectiveness of various therapies in altering autoantibody repertoires. We find that therapies targeting B-Cell Maturation Antigen (BCMA) profoundly alter an individuals autoreactome, while anti-CD19 and CD-20 therapies have minimal effects, strongly suggesting a rationale for BCMA or other plasma cell targeted therapies in autoantibody mediated diseases.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2024 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        Â· Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
